Deletions of CDKN2C in Multiple Myeloma: Biological and Clinical Implications

PURPOSE: Deletions of chromosome 1 have been described in 7-40% of cases of myeloma with inconsistent clinical consequences. CDKN2C at 1p32.3 has been identified in myeloma cell lines as the potential target of the deletion. We tested the clinical impact of 1p deletion and used high resolution techn...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Leone, Paola E., Walker, Brian A., Jenner, Matthew W., Chiecchio, Laura, Dagrada, GianPaolo, Protheroe, Rebecca K.M., Johnson, David C., Dickens, Nicholas J., Brito, Jose Luis, Else, Monica, Gonzalez, David, Ross, Fiona M., Chen-Kiang, Selina, Davies, Faith E., Morgan, Gareth J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2008
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2581792/
https://ncbi.nlm.nih.gov/pubmed/18829482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-08-0347
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak